Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file)

Thomas RE Barnes; Carol  Paton; Gavin  Herrington; Olivia  Rendora; Elena Maria  Edokpolor Pernia; Kitty  Marshall; Delia Bishara; Alistair  Burns; Phyo Kyaw Myint

Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file)

Thomas RE Barnes, Carol Paton, Gavin Herrington, Olivia Rendora, Elena Maria Edokpolor Pernia, Kitty Marshall, Delia Bishara, Alistair Burns, Phyo Kyaw Myint

Research output: Book/Report › Other Report

Abstract

This report presents the results of the baseline audit for a quality improvement programme (QIP) addressing Topic 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. During July and August, 57 NHS Trusts/healthcare organisations (See Appendix B) participated in this baseline audit, submitting data for 7915 patients under the care of 439 clinical teams.

Original language	English
Place of Publication	London
Publisher	Royal College of Psychiatrists
Number of pages	68
Volume	Audit report 22a
Publication status	Published - 1 Jan 2024

Bibliographical note

Acknowledgements
Thanks are due to all the clinical and clinical audit staff in the participating Trusts/healthcare organisations who took part in the collection and submission of the audit data

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Fingerprint

Dive into the research topics of 'Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file)'. Together they form a unique fingerprint.

Cite this

Barnes, T. RE., Paton, C., Herrington, G., Rendora, O., Edokpolor Pernia, E. M., Marshall, K., Bishara, D., Burns, A., & Myint, P. K. (2024). Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file). Royal College of Psychiatrists.

Barnes, TRE, Paton, C, Herrington, G, Rendora, O, Edokpolor Pernia, EM, Marshall, K, Bishara, D, Burns, A & Myint, PK 2024, Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file). vol. Audit report 22a, Royal College of Psychiatrists, London.

@book{27ff48cd445d4bb78415650a8acc8f69,

title = "Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people{\textquoteright}s mental health services. CCQI 457 (data on file)",

abstract = "This report presents the results of the baseline audit for a quality improvement programme (QIP) addressing Topic 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people{\textquoteright}s mental health services. During July and August, 57 NHS Trusts/healthcare organisations (See Appendix B) participated in this baseline audit, submitting data for 7915 patients under the care of 439 clinical teams.",

author = "Barnes, {Thomas RE} and Carol Paton and Gavin Herrington and Olivia Rendora and {Edokpolor Pernia}, {Elena Maria} and Kitty Marshall and Delia Bishara and Alistair Burns and Myint, {Phyo Kyaw}",

note = "Acknowledgements Thanks are due to all the clinical and clinical audit staff in the participating Trusts/healthcare organisations who took part in the collection and submission of the audit data",

year = "2024",

month = jan,

day = "1",

language = "English",

volume = "Audit report 22a",

publisher = "Royal College of Psychiatrists",

address = "United Kingdom",

}

TY - BOOK

T1 - Prescribing Observatory for Mental Health (2024). QI programme 22a

T2 - The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file)

AU - Barnes, Thomas RE

AU - Paton, Carol

AU - Herrington, Gavin

AU - Rendora, Olivia

AU - Edokpolor Pernia, Elena Maria

AU - Marshall, Kitty

AU - Bishara, Delia

AU - Burns, Alistair

AU - Myint, Phyo Kyaw

N1 - Acknowledgements Thanks are due to all the clinical and clinical audit staff in the participating Trusts/healthcare organisations who took part in the collection and submission of the audit data

PY - 2024/1/1

Y1 - 2024/1/1

N2 - This report presents the results of the baseline audit for a quality improvement programme (QIP) addressing Topic 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. During July and August, 57 NHS Trusts/healthcare organisations (See Appendix B) participated in this baseline audit, submitting data for 7915 patients under the care of 439 clinical teams.

AB - This report presents the results of the baseline audit for a quality improvement programme (QIP) addressing Topic 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. During July and August, 57 NHS Trusts/healthcare organisations (See Appendix B) participated in this baseline audit, submitting data for 7915 patients under the care of 439 clinical teams.

UR - https://www.rcpsych.ac.uk/improving-care/ccqi/national-clinical-audits/pomh/latest-news

M3 - Other Report

VL - Audit report 22a

BT - Prescribing Observatory for Mental Health (2024). QI programme 22a

PB - Royal College of Psychiatrists

CY - London

ER -

Prescribing Observatory for Mental Health (2024). QI programme 22a: The use of medicines with anticholinergic (antimuscarinic) properties in older people’s mental health services. CCQI 457 (data on file)

Abstract

Bibliographical note

UN SDGs

Other files and links

Fingerprint

Cite this